[AVGR] Avinger, Inc.

Overview

Type of security: Stock

Sector: Health Care

Industry: Medical/Dental Instruments

Market Capitalization:

Exchange: NASDAQ

The data is delayed by 15 minutes.

 

Price: 4.1 Change: 0.1 (2.5%)
Ext. hours: Change: 0 (0%)

chart AVGR

Refresh chart

Strongest Trends Summary For AVGR

AVGR is in the long-term down -100% below S&P in 5 years.

Horizon: 3 hours | 2 days | 5 days | 10 days | 1 month | 6 months | 1 year | 2 years | 5 years | max

Chart type: absolute | relative to S&P

Publish chart

 

See how to gain 20% in 14 sec with TrendsInvesting

Fundamental Ratios
Shares Outstanding EPS-3.01 EPS Growth - 4 Quarters EPS Growth - Q/Q
EPS Growth - Y/Y Sales Growth - 4 Quarters -32.05% Sales Growth - Q/Q-32.05% P/E-0.16
P/E To EPS Growth P/S P/BV Price/Cash Per Share
Price/Free Cash Flow ROA-23.22% ROE-43.56% ROI-27.02%
Current Ratio6.8 Quick Ratio6.44 Long Term Debt/Equity0.4 Debt Ratio0.26
Gross Margin44.58% Operating Margin-317.79% Net Profit Margin-359.47% Dividend Payout Ratio
Dividend Yield
Fundamental Data
Cash From Financing Activities65.22 M Cash From Investing Activities-210 K Cash From Operating Activities-7.92 M Gross Profit800 K
Net Profit-10.42 M Operating Profit-9.43 M Total Assets79.89 M Total Current Assets76.37 M
Total Current Liabilities11.23 M Total Debt29.56 M Total Liabilities37.3 M Total Revenue2.09 M
Technical Data
High 52 week8.6 Low 52 week0.19 Last close0.31 Last change-0.16%
RSI52.91 Average true range0.04 Beta0.84 Volume120.46 K
Simple moving average 20 days12.69% Simple moving average 50 days-1.74% Simple moving average 200 days-72.6%
Performance Data
Performance Week9.64% Performance Month-9.71% Performance Quart-74.63% Performance Half-80.81%
Performance Year-96.43% Performance Year-to-date2.33% Volatility daily10.62% Volatility weekly23.74%
Volatility monthly48.66% Volatility yearly168.56% Relative Volume348.92% Average Volume1.65 M
New High New Low

News

2019-06-21 16:05:00 | Avinger to Effect One-for-Ten Reverse Stock Split

2019-06-04 07:00:00 | Avinger Announces Distribution Agreement for Hong Kong

2019-05-30 16:00:00 | Avinger Announces Presentations by Key Opinion Leaders at New Cardiovascular Horizons Annual Conference

2019-05-24 09:30:01 | Is Avinger AVGR Stock Outpacing Its Medical Peers This Year?

2019-05-16 07:30:00 | Avinger Announces Successful Treatment of 1,000th Patient with Next-Generation Pantheris Device

2019-05-09 00:07:52 | Edited Transcript of AVGR earnings conference call or presentation 8-May-19 8:30pm GMT

2019-05-08 17:28:24 | Avinger: 1Q Earnings Snapshot

2019-05-08 16:01:00 | Avinger Provides First Quarter 2019 Shareholder Update

2019-05-08 14:30:00 | Avinger, Inc. to Host Earnings Call

2019-05-03 09:30:01 | Is Avinger AVGR Outperforming Other Medical Stocks This Year?

2019-05-02 17:45:09 | Avinger AVGR Dips More Than Broader Markets: What You Should Know

2019-05-02 12:25:00 | Avinger to Announce First Quarter 2019 Financial Results on May 8, 2019

2019-04-17 08:00:00 | Avinger Announces Issuance of New U.S. Patent and Receives Notice of Allowance for Five Additional U.S. Patents

2019-04-15 08:00:00 | Avinger Announces Publication of Study Demonstrating Positive Clinical Outcomes for Patients Treated with Pantheris Prior to Antirestenotic Therapy

2019-04-11 09:39:01 | Top Ranked Momentum Stocks to Buy for April 11th

2019-04-10 08:39:12 | EDAP TMS EDAP Looks Good: Stock Adds 7.9% in Session

2019-04-10 08:00:00 | Avinger Receives FDA Clearance of Pantheris SV Device

2019-04-09 08:14:12 | Top Ranked Momentum Stocks to Buy for April 9th

2019-03-27 08:00:00 | Avinger Receives $6.2 Million from Warrant Exercises

2019-03-07 18:01:09 | Edited Transcript of AVGR earnings conference call or presentation 6-Mar-19 9:30pm GMT

2019-03-06 16:05:00 | Avinger Provides Fourth Quarter and Full Year 2018 Shareholder Update

2019-03-06 07:50:27 | Avinger's Q4 Earnings Outlook

2019-03-01 08:30:00 | Avinger to Present at Oppenheimer Healthcare Conference on March 20

2019-02-28 08:30:00 | Avinger to Announce Fourth Quarter and Full Year 2018 Financial Results on March 6, 2019

2019-01-28 08:00:00 | Avinger’s Pantheris SV Small Vessel Featured in Live Case Transmission at Leipzig Interventional Course LINC 2019

2019-01-16 10:16:03 | Zacks.com featured highlights include: G-III, SP Plus, Penske Automotive, aTyr and Avinger

2019-01-15 06:23:11 | What Bargain Hunting? Tap 5 Stocks With Rising P/E

2018-12-28 07:06:12 | 5 Top Rising P/E Stocks to Enjoy Solid Gains

2018-12-19 06:00:00 | Avinger Announces Preliminary Analysis of Results from SCAN Clinical Study

2018-12-13 07:00:00 | Avinger Announces Successful Treatment of 500th Patient with Next-Generation Pantheris Device

2018-12-06 09:15:00 | New Healthcare Trends Pushing Stocks Higher On Thursday

2018-12-06 08:00:00 | Avinger Announces Commercial Launch in Australia

2018-11-29 08:06:01 | Zacks.com highlights: Asbury Automotive, OncoGenex Pharmaceuticals, aTyr Pharma, Avinger and Sunesis Pharmaceuticals

2018-11-28 07:04:12 | 5 Top-Ranked Rising P/E Stocks to Lure Investors

2018-11-21 08:50:00 | Market Trends Toward New Normal in Wilhelmina International, Eyenovia, aTyr Pharma, Avinger, Viacom, and Axsome Therapeutics — Emerging Consolidated Expectations, Analyst Ratings

2018-11-15 08:55:00 | Avinger Announces Successful Treatment of First Patients Globally with Pantheris SV, a New Image-Guided Atherectomy Device Designed to Treat Smaller Vessels

2018-11-14 14:22:16 | Avinger: 3Q Earnings Snapshot

2018-11-14 07:21:59 | Edited Transcript of AVGR earnings conference call or presentation 13-Nov-18 9:30pm GMT

2018-11-13 15:01:00 | Avinger Provides Third Quarter 2018 Shareholder Update

2018-11-07 07:45:00 | Avinger to Present at the Canaccord Genuity Medical Technologies & Diagnostics Forum 2018

2018-11-05 06:30:00 | Avinger to Announce Third Quarter 2018 Financial Results on November 13, 2018

2018-11-01 16:05:00 | Avinger Announces Closing of $11.5 Million Underwritten Public Offering and Full Exercise of Over-Allotment Option

2018-10-30 08:30:00 | Avinger Announces Pricing of $10 Million Underwritten Public Offering

2018-10-18 08:30:00 | Avinger Receives CE Marking Approval for Pantheris SV, a New Image-Guided Atherectomy Device Designed to Treat Smaller Vessels

2018-09-05 08:30:00 | Avinger Announces Successful Treatment of 200th Patient with Next-Generation Pantheris Device

2018-08-30 08:30:00 | Avinger Announces 510k Filing of Pantheris Small Vessel Device

2018-08-29 08:30:00 | Avinger Receives New Patent Covering Pantheris Image-Guided Atherectomy System

2018-08-28 08:30:00 | Avinger Announces Participation in Upcoming Investor Conferences

2018-08-23 08:30:00 | Avinger Completes Enrollment in SCAN Clinical Study

2018-08-13 19:35:13 | Edited Transcript of AVGR earnings conference call or presentation 13-Aug-18 9:00pm GMT